General Range
FORLEVO IV
Price on request/100 · MOQ 100 boxes
FORLEVO IV Infusion by Fortune Labs contains Levofloxacin 500 mg/100 ml, a fluoroquinolone antibiotic used to treat selected bacterial infections caused by susceptible microorganisms. Levofloxacin works by inhibiting bacterial DNA replication, helping control bacterial growth and infection. FORLEVO IV may be prescribed for pneumonia, complicated urinary tract infections, kidney infections, and certain skin infections when clinically appropriate. Available in a 100 ml sterile, single-dose infusion container, this product is part of Fortune Labs' injectable pharmaceutical portfolio. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, and franchise enquiries. Administer only under qualified medical supervision due to potentially serious fluoroquinolone-related adverse effects.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Levofloxacin 500 mg/100 ml
- Packaging Type
- Sterile Plastic Infusion Bottle with Outer Carton
- Packaging Size
- 100ml
- Dosage Form
- Intravenous Infusion
- Treatment
- Bacterial respiratory tract infections, pneumonia, complicated urinary tract infections, kidney infections, skin and soft tissue infections, and other
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
